Rene David Insider Profile
4 Followers
Rene David, Chief Operating Officer at Abattis Bioceuticals, holds 20.16M shares in Abattis Bioceuticals (Ticker: ATTBF).
Rene David's Trading History
| ATTBFAbattis Bioceuticals | Jun 28, 2018 | Chief Operating Officer | Uninformative Buy | 691.58K | ― | |||||||||||||||||||||||||||||||||||||||||||
ATTBF Insider Shares: 20.16M (571.82%)
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Rene David insider profile FAQ
What is the percentage of profitable transactions made by Rene David?
The percentage of profitable transactions made by Rene David is 35%.
What is the average return per transaction made by Rene David?
The average return per transaction made by Rene David is 5.90%.
What stocks does Rene David hold?
Rene David holds: ATTBF stocks.
What was Rene David’s latest transaction?
Rene David’s latest transaction was an Uninformative Buy of $691.58K.
What was Rene David's most profitable transaction?
Rene David’s most profitable transaction was an Informative Buy of ATTBF stock on June 7, 2016. The return on the trade was 238.20%.
What is Rene David's role in Abattis Bioceuticals?
Rene David's role in Abattis Bioceuticals is Chief Operating Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
